Response to Preoperative Dexamethasone Predicts Postoperative Neurological Improvement of Focal Neurological Deficits in Patients With Brain Metastases

BACKGROUND: Steroids are used ubiquitously in the preoperative management of patients with brain tumor. The rate of improvement in focal deficits with steroids and the prognostic value of such a response are not known. OBJECTIVE: To determine the rate at which focal neurological deficits respond to preoperative corticosteroids in patients with brain metastases and whether such an improvement could predict long-term recovery of neurological function after surgery. METHODS: Patients with brain metastases and related deficits in language, visual field, or motor domains who received corticosteroids before surgery were identified. Characteristics between steroid responders and nonresponders were compared. RESULTS: Ninety six patients demonstrated a visual field (13 patients), language (19), or motor (64) deficit and received dexamethasone in the week before surgery (average cumulative dose 43 mg; average duration 2.7 days). 38.5% of patients' deficits improved with steroids before surgery, while 82.3% of patients improved by follow-up. Motor deficits were more likely to improve both preoperatively (P = .014) and postoperatively (P = .010). All 37 responders remained improved at follow-up whereas 42 of 59 (71%) of nonresponders ultimately improved (P < .001). All other clinical characteristics, including dose and duration, were similar between groups. CONCLUSION: A response to steroids before surgery is highly predictive of long-term improvement postoperatively in brain metastasis patients with focal neurological deficits. Lack of a response portends a somewhat less favorable prognosis. Duration and intensity of therapy do not seem to affect the likelihood of response.

• Publication year

  2023

• Venue

  Neurosurgery

• Publication date

  2023-01-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/neu.0000000000002353PMID 36728251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Operative and peri‐operative considerations in the management of brain metastasis

  2019cited by this paper
• Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group

  2018cited by this paper
• Surgery on motor area metastasis

  2015cited by this paper
• Medical management of brain tumors and the sequelae of treatment.

  2015cited by this paper
• The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

  2014cited by this paper
• Steroid management in newly diagnosed glioblastoma

  2013cited by this paper
• Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy.

  2013cited by this paper
• Tumor-associated edema in brain cancer patients: pathogenesis and management

  2013cited by this paper
• Perioperative Steroids for Peritumoral Intracranial Edema: A Review of Mechanisms, Efficacy, and Side Effects

  2012cited by this paper
• Corticosteroids in brain cancer patients: benefits and pitfalls

  2011cited by this paper
• The use and toxicity of steroids in the management of patients with brain metastases

  2008cited by this paper
• Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma.

  2006cited by this paper
• EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

  2006cited by this paper
• Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging

  2005cited by this paper
• Current management of brain metastases, with a focus on systemic options.

  2005cited by this paper
• Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study

  2004cited by this paper
• Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?

  2002cited by this paper
• Differences in Blood-Tumour-Barrier Leakage of Human Intracranial Tumours: Quantitative Monitoring of Vasogenic Oedema and its Response to Glucocorticoid Treatment

  1998cited by this paper
• Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors

  1994cited by this paper
• Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone.

  1987cited by this paper
• Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone.

  1987cited by this paper
• Use of dexamethasone in treatment of cerebral edema associated with brain tumors.

  1961cited by this paper

• Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations.

  2024cites this paper